X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (424) 424
Journal Article (385) 385
Conference Proceeding (26) 26
Publication (12) 12
Book Chapter (3) 3
Book Review (3) 3
Book / eBook (2) 2
Technical Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electricity (302) 302
electric communication technique (222) 222
pictorial communication, e.g. television (154) 154
humans (140) 140
index medicus (98) 98
physics (97) 97
male (94) 94
female (90) 90
performing operations (83) 83
transporting (83) 83
transmission of digital information, e.g. telegraphiccommunication (81) 81
middle aged (80) 80
aged (76) 76
basic electric elements (72) 72
information storage (67) 67
information storage based on relative movement between recordcarrier and transducer (67) 67
oncology (62) 62
processes or means, e.g. batteries, for the direct conversionof chemical into electrical energy (61) 61
mechanical metal-working without essentially removingmaterial (54) 54
punching metal (54) 54
rolling of metal (52) 52
chemistry (51) 51
metallurgy (50) 50
chemotherapy (46) 46
adult (45) 45
cancer (42) 42
animals (39) 39
medicine & public health (36) 36
treatment outcome (33) 33
aged, 80 and over (30) 30
calculating (30) 30
computing (30) 30
counting (30) 30
biochemistry & molecular biology (29) 29
general tagging of cross-sectional technologies spanning over several sections of the ipc (27) 27
general tagging of new technological developments (27) 27
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (27) 27
transmission (27) 27
analysis (26) 26
electric digital data processing (26) 26
metastasis (26) 26
japan (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
basic electronic circuitry (24) 24
general devices for heat treatment of ferrous or non-ferrousmetals or alloys (23) 23
making metal malleable by decarburisation, tempering or othertreatments (23) 23
metallurgy of iron (23) 23
modifying the physical structure of ferrous metals (23) 23
patients (23) 23
wireless communications networks (23) 23
gastroenterology & hepatology (21) 21
surgery (21) 21
trial (20) 20
care and treatment (19) 19
diagnosis (19) 19
esophageal cancer (19) 19
research (19) 19
fluorouracil - administration & dosage (18) 18
surgical oncology (18) 18
technical subjects covered by former uspc (18) 18
biophysics (17) 17
molecular sequence data (17) 17
stomach cancer (17) 17
tumors (17) 17
cancer research (16) 16
colorectal cancer (16) 16
cisplatin (15) 15
fluorouracil (15) 15
mice (15) 15
multiplex communication (15) 15
original (15) 15
therapy (15) 15
clinical trials (14) 14
gastroenterology (14) 14
retrospective studies (14) 14
stomach neoplasms - drug therapy (14) 14
alloys (13) 13
antineoplastic agents - therapeutic use (13) 13
gastric cancer (13) 13
risk factors (13) 13
technical subjects covered by former us classification (13) 13
amino acid sequence (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
base sequence (12) 12
cancer therapies (12) 12
clinical neurology (12) 12
combination (12) 12
deoxycytidine - analogs & derivatives (12) 12
diabetes (12) 12
drug therapy (12) 12
ferrous or non-ferrous alloys (12) 12
prognosis (12) 12
treatment of alloys or non-ferrous metals (12) 12
adenocarcinoma (11) 11
antimitotic agents (11) 11
antineoplastic agents (11) 11
apparatus therefor (11) 11
bevacizumab (11) 11
code conversion in general (11) 11
coding (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Disease, ISSN 2072-1439, 06/2018, Volume 10, Issue Suppl 17, pp. S2086 - S2088
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 631 - 639
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 35, pp. 4438 - 4444
Journal Article
Cancer Science, ISSN 1347-9032, 04/2015, Volume 106, Issue 4, pp. 397 - 406
This study aimed to evaluate the feasibility of and immune response to Wilms tumor gene 1 (WT1) peptide‐pulsed dendritic cell vaccination combined with... 
first‐line therapy | neutrophil lymphocyte ratio | dendritic cell vaccination | Delayed‐type hypersensitivity | immunotherapy | Neutrophil lymphocyte ratio | Delayed-type hypersensitivity | Dendritic cell vaccination | First-line therapy | Immunotherapy | first-line therapy | BILIARY-TRACT CANCER | DUCTAL ADENOCARCINOMA | COMBINATION | TRIAL | THERAPY | ONCOLOGY | WT1 | SUPPRESSOR-CELLS | RESISTANT PROSTATE-CANCER | CARCINOMA | Dendritic Cells - immunology | Humans | Middle Aged | Vaccination | Male | Cancer Vaccines - therapeutic use | Deoxycytidine - therapeutic use | WT1 Proteins - pharmacology | C-Reactive Protein - metabolism | WT1 Proteins - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Interleukin-8 - blood | Liver Neoplasms - secondary | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Neutrophils - immunology | Treatment Outcome | Combined Modality Therapy | Cancer Vaccines - immunology | Antimetabolites, Antineoplastic - therapeutic use | Pilot Projects | Pancreatic Neoplasms - immunology | Lymphocyte Count | Aged | CD8-Positive T-Lymphocytes - immunology | Dendritic Cells - transplantation | Deoxycytidine - analogs & derivatives | Pancreatic Neoplasms - therapy | Gemcitabine | Peptides | Hypersensitivity (delayed) | Genes | Liver | Clinical trials | Metastasis | Suppressor cells | Cancer therapies | Metastases | Liver cancer | Consent | Peripheral blood | Growth factors | Antigens | Dendritic cells | Inflammation | FDA approval | Disease control | Patients | Studies | Chemotherapy | Pancreatic cancer | Medical prognosis | Response rates | Interferon | Histocompatibility antigen HLA | Prostate cancer | Skin tests | Tumors | Original
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0122521
Objective Poor sleep quality is an independent predictor of cardiovascular events. However, little is known about the association between glycemic control and... 
HEMOGLOBIN | INSOMNIA | COMPLAINTS | RISK-FACTOR | DEPRIVATION | EEG | MULTIDISCIPLINARY SCIENCES | DISEASE | JAPAN | ATHEROSCLEROSIS | BLOOD-PRESSURE | Blood Pressure | Carotid Arteries - metabolism | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Sleep Initiation and Maintenance Disorders - pathology | Hyperglycemia - complications | Male | Electroencephalography | Sleep Initiation and Maintenance Disorders - complications | Hyperglycemia - pathology | Adult | Female | Sleep, REM | Arteriosclerosis - blood | Diabetes Mellitus, Type 2 - complications | Cross-Sectional Studies | Carotid Intima-Media Thickness | Risk Factors | Arteriosclerosis - complications | Sleep Initiation and Maintenance Disorders - blood | Diabetes Mellitus, Type 2 - blood | Hyperglycemia - blood | Aged | Carotid Arteries - pathology | Diabetes Mellitus, Type 2 - pathology | Blood Glucose - metabolism | Arteriosclerosis - pathology | Diabetics | Care and treatment | Sleep | Chronic kidney failure | Analysis | Diabetes | Diabetes therapy | Fourier transforms | Independent variables | Cardiovascular disease | Sleep (REM) | Sleep deprivation | Sleep disorders | Atherosclerosis | Blood pressure | Carotid artery | University graduates | Thickening | Heart failure | Hypertension | Architecture | Diabetes mellitus | Metabolism | Patients | Latency | Medicine | Insomnia | Arteriosclerosis | Kidney diseases | Endocrinology
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2012, Volume 15, Issue 3, pp. 313 - 322
The Trastuzumab for Gastric Cancer (ToGA) study is the first international trial to include Japanese patients with human epidermal growth factor 2 (HER2)... 
Pathology | Medicine & Public Health | Gastroenterology | Oncology | Radiotherapy | Drug therapy | Surgical Oncology | Randomized controlled trial | Trastuzumab | Stomach neoplasms | CAPECITABINE | THERAPY | CISPLATIN | ONCOLOGY | PHASE-III | GASTROENTEROLOGY & HEPATOLOGY | CHEMOTHERAPY | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Stomach Neoplasms - metabolism | Male | Cisplatin - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Esophageal Neoplasms - metabolism | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Female | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Proportional Hazards Models | Survival Rate | Stomach Neoplasms - drug therapy | Asian Continental Ancestry Group | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Medical colleges | Oncology, Experimental | College teachers | Metastasis | Research | Stomach cancer | Biometry | Chemotherapy | Epidermal growth factor | Analysis | Cross infection | Diabetes | Kidney diseases | Nosocomial infections | Public health | Cancer | Fluorouracil | Original
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2016, Volume 19, Issue 3, pp. 902 - 910
Journal Article